On Pharmacogenomics in Pharmacy Benefit Management

2012 ◽  
Vol 32 (2) ◽  
pp. 103-111 ◽  
Author(s):  
J. Russell Teagarden ◽  
Eric J. Stanek
Keyword(s):  
Pharmacy Benefit Management ◽  
Pharmacy Benefit

Naltrexone and Pharmacy Benefit Management

2004 ◽  
Vol 23 (4) ◽  
pp. 11-29 ◽  
Author(s):  
Katherine M. Harris ◽  
Cindy Thomas
Keyword(s):  
Pharmacy Benefit Management ◽  
Pharmacy Benefit

Examining the value of pharmacy benefit management companies

2004 ◽  
Vol 61 (1) ◽  
pp. 81-85 ◽  
Author(s):  
Robert I. Garis ◽  
Bartholomew E. Clark ◽  
Mark V. Siracuse ◽  
Michael C. Makoid
Keyword(s):  
Pharmacy Benefit Management ◽  
Pharmacy Benefit

scholarly journals Consumption of antihypertensive drugs dispensed under the pharmacy benefit management program

2011 ◽  
Vol 47 (4) ◽  
pp. 807-815
Author(s):  
Aline Pereira Rocha ◽  
Brigitte Rieckmann Martins dos Santos
Keyword(s):  
Antihypertensive Drugs ◽  
Patient Adherence ◽  
Age Groups ◽  
Management Program ◽  
Age Group ◽  
Pharmacy Benefit Management ◽  
Antihypertensive Medications ◽  
Pharmacy Benefit ◽  
Treatment Of Hypertension ◽  
The Mean

Pharmacy benefit management (PBM) programs provide attractive discounts for drug purchase, a relevant measure to address costs, mainly of drugs for the treatment of chronic diseases. This study investigated whether PBM may be used as a tool to provide information about the use of antihypertensive medications when they are purchased. The profile of medicines taken to treat high blood pressure by large IT company employees and their dependents was evaluated from January to December 2009. The mean rate of drug boxes purchased to control hypertension was 9.4 ± 10.0 in 2009. Men purchased more drugs than women. The number of drugs purchased for the treatment of hypertension was lower than expected in all age groups except for individuals aged 54-58 and >59 years. Among men, the purchase of drugs to treat hypertension was higher than expected in the 24-28, 34-38 and 54-58 age groups. Among women, results matched expectations, except for the age group 34-38 years, in which purchase was lower than expected. Individuals in the age group 0-18 years were found to consume antihypertensive drugs. Although the PBM system may be used to identify drugs purchased by users, it does not ensure patient adherence to recommended drug treatment to control hypertension.

Sign in / Sign up

Export Citation Format

Share Document